HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

European Court Rules Against GSK/Novartis In Free OTC Samples Case

Executive Summary

The European Court of Justice has ruled that companies should be able to give free samples of OTC medicines to pharmacists, in a local dispute between GSK Consumer Healthcare and its German competitors Ratiopharm. 

You may also be interested in...



UK Probiotics Distribution Deal Latest Milestone In OptiBiotix Growth Journey

UK probiotics specialist Optibiotix' CEO Stephen O'Hara speaks exclusively to HBW Insight about the firm's growth ambitions, which have not been held back by the coronavirus pandemic. 

Don’t Let COVID Bring You Down: New German Immunity Boosters From Stada, Pascoe And More

New German wellness launches: Immunity boosting food supplements from Stada, Pascoe, Dr Scheffler, Queisser and Infecto.

Rx-To-OTC Switch And RWE Key To Creating ‘Crisis Proof’ European Medicines System

Europe's self-care industry urges the European Commission to use Rx-to-OTC switch and real world evidence to widen access to OTC medicines in the region as part of its new pharmaceutical strategy. 

Topics

UsernamePublicRestriction

Register

SC100339

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel